UK News Elert

	LATEST BREAKING UK NEWS PHARMATIMES DAILY POLL: As Shire/TAP and Lilly/Sanofi team up, is co-promotion the best way to control marketing costs? Click here to answer and see yesterday's results SkyePharma gains on upbeat business outlook Shares in UK drugmaker SkyePharma were on the rise this morning after the group posted a flat set of financials for 2007 but gave an upbeat outlook for the coming year on a spate of expected product approvals and launches. read more Practice managers warn of private sector threat to general practice Confidence in the government's drive to open up the primary care arena to the private sector is running low, at least according to the results of a recent survey of practice managers in the UK. read more UK watchdog bans use of cough medicines in under-twos The Medicines and Healthcare products Regulatory Agency has published new guidance advising that over-the-counter cough/cold medicines containing certain ingredients should no longer be given to children under the age of two. read more Public wants more spend and research on Alzheimer's The general public is calling for more research on Alzheimer's disease, a new survey by the ABPI, carried out to investigate whether current research ties up with public concerns and NHS priorities, has revealed. read more more stories below Shire and TAP to co-promote ulcerative colitis drug Lialda On the day it received a boost from a positive analyst report, Shire has signed up TAP Pharmaceutical Products to help sell its new bowel disorder drug Lialda read more Government hands out £42 million to fund new research programmes The government has promised to inject a hefty investment of £42 million into new research programmes designed to improve service delivery in children's health and other under-funded areas. read more Inhaled corticosteroids given the thumbs up by NICE for asthma NICE has published final guidance this morning recommending the use of inhaled corticosteroids for the treatment of chronic asthma in adults and children from 12 years of age on the NHS. read more UK's NICE endorses use of Sanofi-Aventis' Acomplia on NHS Obese patients in the UK are a step closer to getting easier access to Sanofi-Aventis' weight loss drug Acomplia, after the country's spending watchdog proposed recommending its use on the National Health Service. read more OTHER HEADLINES WORLD Tight FDA deadlines increase drug safety concerns …while CDER chief rejects claims agency is over-cautious US regulator probes possible suicide link to Singulair CLINICAL Patients will benefit from hybrid embryos, charities insist Stem cells may have most potential as drug development tools Manchester partnership awarded Biomedical Research Centres status UK UK Code of Practice complaints down in 2007 Patient choice extended to any NHS hospital in England UK drugmakers to slash jobs and R&D, govt warned You have received this mailing because you are part of the PharmaTimes UK News Online mailing list. If you wish to stop receiving these daily mailings please send an e-mail to uk_news-request@pharmatimes.com with the subject "unsubscribe". Registered in England & Wales at: The Coach House, 173 Sheen Lane, East Sheen, London SW14 8NA Company Registration Number: 2331805 © 2008 PharmaTimes Tel: +44 (0) 20 8878 8566 Fax: +44 (0) 20 8876 8834 www.pharmatimes.com